Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK21542 Injection for Postoperative Pain (Phase III)
CTR20220978Phase 3Completed
- Sponsor
- Liaoning Haisco Pharmaceutical Co., Ltd.
- Start
- Jun 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of hsk21542 in postoperative pain, sponsored by Liaoning Haisco Pharmaceutical Co., Ltd.. Started Jun 2022; status: completed.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20220978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220978.